RETRACTION: Retraction: Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer

被引：0
|
作者：
Li, Chunpu [1 ,2 ,3 ]
Cai, Gang [1 ,2 ]
Song, Daqian [1 ,2 ]
Gao, Ruixuan [2 ,3 ]
Teng, Peng [2 ,3 ]
Zhou, LiHong [1 ,2 ]
Ji, Qing [1 ,2 ]
Sui, Hua [1 ,2 ]
Cai, Jianfeng [3 ]
Li, Qi [1 ,2 ]
Wang, Yan [1 ,2 ]
机构：
[1] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Acad Integrat Med, Dept Med Oncol, Shanghai, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Canc Inst Med, Acad Integrat Med, Shanghai, Peoples R China
[3] Univ S Florida, Dept Chem, 4202 E Fowler Ave, Tampa, FL 33620 USA
来源：
BIOMATERIALS SCIENCE | 2024年 / 12卷 / 22期
关键词：
D O I：
10.1039/d4bm90079k
中图分类号：
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号：
0805 ; 080501 ; 080502 ;
摘要：
引用
收藏
页码：5872 / 5872
页数：1
相关论文
共 50 条
  • [1] Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer
    Li, Chunpu
    Cai, Gang
    Song, Daqian
    Gao, Ruixuan
    Teng, Peng
    Zhou, LiHong
    Ji, Qing
    Sui, Hua
    Cai, Jianfeng
    Li, Qi
    Wang, Yan
    BIOMATERIALS SCIENCE, 2019, 7 (09) : 3627 - 3639
  • [2] EGFR-Targeted therapies in colorectal cancer
    Overman, Michael J.
    Hoff, Paulo M.
    DISEASES OF THE COLON & RECTUM, 2007, 50 (08) : 1259 - 1270
  • [3] Acquired resistance to EGFR-targeted therapies in colorectal cancer
    Van Emburgh, Beth O.
    Sartore-Bianchi, Andrea
    Di Nicolantonio, Federica
    Siena, Salvatore
    Bardelli, Alberto
    MOLECULAR ONCOLOGY, 2014, 8 (06) : 1084 - 1094
  • [4] Clinical results of EGFR-targeted therapies in advanced colorectal cancer
    Maiello, Evaristo
    Gebbia, Vittorio
    Manzione, Luigi
    Giuliani, Francesco
    Morelli, Franco
    Arcara, Carlo
    Grimaldi, Antonio
    Colucci, Giuseppe
    EJC SUPPLEMENTS, 2008, 6 (14): : 64 - 69
  • [5] Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies
    Simonetta M. Leto
    Livio Trusolino
    Journal of Molecular Medicine, 2014, 92 : 709 - 722
  • [6] HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer
    Sartore-Bianchi, Andrea
    Amatu, Alessio
    Porcu, Luca
    Ghezzi, Silvia
    Lonardi, Sara
    Leone, Francesco
    Bergamo, Francesca
    Fenocchio, Elisabetta
    Martinelli, Erika
    Borelli, Beatrice
    Tosi, Federica
    Racca, Patrizia
    Valtorta, Emanuele
    Bonoldi, Emanuela
    Martino, Cosimo
    Vaghi, Caterina
    Marrapese, Giovanna
    Ciardiello, Fortunato
    Zagonel, Vittorina
    Bardelli, Alberto
    Trusolino, Livio
    Torri, Valter
    Marsoni, Silvia
    Siena, Salvatore
    ONCOLOGIST, 2019, 24 (10): : 1395 - 1402
  • [7] Transcriptional modules predicting response of colorectal cancer to EGFR-targeted therapy
    Medico, E.
    Picco, G.
    Isella, C.
    Petti, C.
    EJC SUPPLEMENTS, 2010, 8 (05): : 201 - 201
  • [8] Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer
    Spano, Jean Philippe
    Milano, Gerard
    Vignot, Stephane
    Khayat, David
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (01) : 21 - 30
  • [9] EGFR-targeted hybrid lipid nanoparticles for chemo-photothermal therapy against colorectal cancer cells
    Fang, Fang
    Zhang, Xinming
    Tang, Jin
    Wang, Yu
    Xu, Jinchen
    Sun, Yu
    CHEMISTRY AND PHYSICS OF LIPIDS, 2023, 251
  • [10] Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies
    Leto, Simonetta M.
    Trusolino, Livio
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2014, 92 (07): : 709 - 722
12345